Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US17271479Application Date: 2019-09-06
-
Publication No.: US11932657B2Publication Date: 2024-03-19
- Inventor: Kazuhiro Ohdachi , Yusuke Fujimori , Naoya Makita , Noritaka Koseki , Hideki Hayashi , Yuki Sakamoto , Kurumi Mineno , Ryosuke Taga
- Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP 18167488 2018.09.07
- International Application: PCT/JP2019/035233 2019.09.06
- International Announcement: WO2020/050409A 2020.03.12
- Date entered country: 2021-02-25
- Main IPC: C07D513/14
- IPC: C07D513/14 ; C07D498/14 ; C07D519/00
Abstract:
Provided is a novel heterocyclic compound having an aryl hydrocarbon receptor antagonist activity and useful for the promotion of platelet production, the compound being represented by the general formula [I]: wherein ring A, ring B, R1, R2, R3, R4, n, and X are as defined above, or a salt thereof.
Public/Granted literature
- US20210340157A1 HETEROCYCLIC COMPOUND Public/Granted day:2021-11-04
Information query
